22Nd Century Group, Inc. (XXII) SEC Filing 10-Q Quarterly report for the period ending Tuesday, June 30, 2020

SEC Filings

22Nd Century Group, Inc.

CIK: 1649009 Ticker: XXII

Exhibit 99.1


22nd Century Group Reports Financial Results and Business Highlights for the Second Quarter 2020


Key Highlights:


·Net sales revenue increased approximately 11% to $6.4 million


·Gross profit continues to show improvement year-over-year as a result of targeted actions to improve margins and cost structure


·Operating loss improved by approximately $276 thousand


·Adjusted EBITDA improved 21%


·Appointed new CEO, James A. Mish and new CFO, John Franzino


WILLIAMSVILLE, N.Y., August 6, 2020 (Globe Newswire)

— 22nd Century Group, Inc. (NYSE American: XXII) (“22nd Century” or “the Company”), a leading plant biotechnology company focused on technologies that alter the level of nicotine in tobacco plants and the level of cannabinoids in hemp/cannabis plants through genetic engineering, gene-editing, and modern plant breeding, today reported results for the second quarter ended June 30, 2020.


“Despite the unprecedented challenges brought on by COVID-19, I am pleased to report net sales revenue of $6.4 million for the second quarter of 2020, up 11% from the prior year, continued gross profit margin expansion, and improved operating loss. These results demonstrate our ability to execute on our initiatives to improve our margins and cost structure. Our financial position remains strong and we will continue to operate with strict cost controls, allocate our resources efficiently, and deploy capital where we believe it will give us the greatest return on our investments,” said James A. Mish, Chief Executive Officer of 22nd Century Group.


“With the comment period now closed on our Modified Risk Tobacco Product Application, the team is laser focused on setting the stage for a successful VLN® launch upon the authorization of our MRTP Application by the FDA. I am exceedingly proud of the dedication and tremendous progress the team has made so far this year and believe we are well positioned to capitalize on the many opportunities ahead,” Mish added.


Business Highlights and Notable Events:


·The Company appointed James A. Mish as its Chief Executive Officer, effective June 22, and John Franzino as its Chief Financial Officer, effective June 3. Mish has extensive global executive leadership experience leading science-driven organizations with a focus on the development, manufacturing, and commercialization of active pharmaceutical ingredients (“API”), including cannabinoids, and related consumer products. Franzino has extensive financial leadership experience in the tobacco and alcoholic beverage industries. Mish is reviewing the Company’s current strategy and objectives and is expected to provide an update in November during the Company’s third quarter earnings call.


·The public comment period for the Company’s Modified Risk Tobacco Product (“MRTP”) Application for VLN® closed on May 18, 2020. The application requests a modified exposure designation from the FDA to market the Company’s proprietary reduced nicotine content tobacco cigarettes in the U.S. under the proposed brand name of VLN® with product labeling and advertising claims stating that VLN® has 95% less nicotine than conventional cigarettes, as well as other claims related to reduced nicotine exposure. The closing of the public comment period marks an important milestone in the FDA’s ongoing scientific review of the Company’s MRTP Application.


The following information was filed by 22Nd Century Group, Inc. (XXII) on Thursday, August 6, 2020 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one quarter to another to evaluate 22Nd Century Group, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by 22Nd Century Group, Inc..


Assess how 22Nd Century Group, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

22Nd Century Group, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (Parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Changes In Shareholders' Equity
Consolidated Statements Of Operations And Comprehensive Loss
Commitments &Amp; Contingencies (Tables)
Commitments And Contingencies
Commitments And Contingencies - Investment, Litigation, Etc. (Details)
Commitments And Contingencies - Licenses (Details)
Earnings Per Share
Earnings Per Share (Details)
Earnings Per Share (Tables)
Earnings Per Share - Anti-Dilutive Securities (Details)
Equity- Based Compensation
Equity- Based Compensation (Tables)
Equity- Based Compensation - Rsus (Details)
Equity- Based Compensation - Stock Option Activity (Details)
Equity-Based Compensation (Details)
Equity-Based Compensation - Compensation Expense (Details)
Fair Value Measurements - Available-For-Sale Securities (Details)
Fair Value Measurements - Changes In Fair Value, Level 3 (Details)
Fair Value Measurements - Maturity Of Available-For-Sale Securities By Contractual Maturity (Details)
Fair Value Measurements - Recurring (Details)
Fair Value Measurements And Short-Term Investments
Fair Value Measurements And Short-Term Investments (Tables)
Intangible Assets
Intangible Assets (Details)
Intangible Assets (Tables)
Inventory (Details)
Inventory (Tables)
Investments &Amp; Convertible Note Receivable
Investments &Amp; Convertible Note Receivable (Details)
Investments &Amp; Convertible Note Receivable (Tables)
Machinery And Equipment
Machinery And Equipment (Details)
Machinery And Equipment (Tables)
Nature Of Business And Summary Of Significant Accounting Policies
Nature Of Business And Summary Of Significant Accounting Policies (Details)
Nature Of Business And Summary Of Significant Accounting Policies (Policies)
Notes Payable
Notes Payable (Details)
Notes Payable (Tables)
Revenue Recognition
Revenue Recognition (Details)
Revenue Recognition (Tables)
Right-Of-Use Assets, Lease Obligations And Other Leases (Details)
Right-Of-Use Assets, Lease Obligations And Other Leases (Tables)
Right-Of-Use Assets, Lease Obligations, And Other Leases
Severance Liability
Severance Liability (Details)
Warrants For Common Stock
Warrants For Common Stock (Details)
Warrants For Common Stock (Tables)
Warrants For Common Stock - Warrant Activity (Details)

Material Contracts, Statements, Certifications & more

22Nd Century Group, Inc. provided additional information to their SEC Filing as exhibits

Ticker: XXII
CIK: 1347858
Form Type: 10-Q Quarterly Report
Accession Number: 0001558370-20-009503
Submitted to the SEC: Thu Aug 06 2020 7:30:44 AM EST
Accepted by the SEC: Thu Aug 06 2020
Period: Tuesday, June 30, 2020
Industry: Cigarettes

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: